Targeting phosphoglycerate dehydrogenase in multiple myeloma.
Samah ElsaadiIda SteiroPegah AbdollahiEsten N VandsembRui YangTobias S SlørdahlTorstein Baade RøEline MenuAnne-Marit SponaasMagne BørsetPublished in: Experimental hematology & oncology (2021)
Our study shows the therapeutic potential of targeting PHGDH in MM, and suggest it as a way to overcome the resistance to proteasome inhibitors.
Keyphrases